Can a blood test reveal which neurons are dying? Renew Biotechnologies’ NeuroLens study takes a significant step forward
Renew Biotechnologies has published peer-reviewed proof-of-concept research showing that native cell-free DNA methylation sequencing can recover neuron-associated blood signals that differ across Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. The results strengthen the scientific rationale behind its NeuroLens platform, but the decisive next step is independent, prospective validation in larger and more diverse patient